These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 31745471)

  • 1. Gut Vibes in Parkinson's Disease: The Microbiota-Gut-Brain Axis.
    Bullich C; Keshavarzian A; Garssen J; Kraneveld A; Perez-Pardo P
    Mov Disord Clin Pract; 2019 Nov; 6(8):639-651. PubMed ID: 31745471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The gut microbiome in Parkinson's disease: A culprit or a bystander?
    Keshavarzian A; Engen P; Bonvegna S; Cilia R
    Prog Brain Res; 2020; 252():357-450. PubMed ID: 32247371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls.
    Unger MM; Spiegel J; Dillmann KU; Grundmann D; Philippeit H; Bürmann J; Faßbender K; Schwiertz A; Schäfer KH
    Parkinsonism Relat Disord; 2016 Nov; 32():66-72. PubMed ID: 27591074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal dysfunction in Parkinson's disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation.
    Metta V; Leta V; Mrudula KR; Prashanth LK; Goyal V; Borgohain R; Chung-Faye G; Chaudhuri KR
    J Neurol; 2022 Mar; 269(3):1154-1163. PubMed ID: 33881598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis.
    Zhao Z; Ning J; Bao XQ; Shang M; Ma J; Li G; Zhang D
    Microbiome; 2021 Nov; 9(1):226. PubMed ID: 34784980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered Gut Microbiome and Intestinal Pathology in Parkinson's Disease.
    Chiang HL; Lin CH
    J Mov Disord; 2019 May; 12(2):67-83. PubMed ID: 31158941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Microbiota and Metabolome Alterations Associated with Parkinson's Disease.
    Vascellari S; Palmas V; Melis M; Pisanu S; Cusano R; Uva P; Perra D; Madau V; Sarchioto M; Oppo V; Simola N; Morelli M; Santoru ML; Atzori L; Melis M; Cossu G; Manzin A
    mSystems; 2020 Sep; 5(5):. PubMed ID: 32934117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The link between the gut microbiota and Parkinson's Disease: A systematic mechanism review with focus on α-synuclein transport.
    Nielsen SD; Pearson NM; Seidler K
    Brain Res; 2021 Oct; 1769():147609. PubMed ID: 34371014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colonic bacterial composition in Parkinson's disease.
    Keshavarzian A; Green SJ; Engen PA; Voigt RM; Naqib A; Forsyth CB; Mutlu E; Shannon KM
    Mov Disord; 2015 Sep; 30(10):1351-60. PubMed ID: 26179554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbes Tickling Your Tummy: the Importance of the Gut-Brain Axis in Parkinson's Disease.
    Perez-Pardo P; Hartog M; Garssen J; Kraneveld AD
    Curr Behav Neurosci Rep; 2017; 4(4):361-368. PubMed ID: 29201595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease.
    Campos-Acuña J; Elgueta D; Pacheco R
    Front Immunol; 2019; 10():239. PubMed ID: 30828335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
    Caputi V; Giron MC
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral and intestinal dysbiosis in Parkinson's disease.
    Berthouzoz E; Lazarevic V; Zekeridou A; Castro M; Debove I; Aybek S; Schrenzel J; Burkhard PR; Fleury V
    Rev Neurol (Paris); 2023 Nov; 179(9):937-946. PubMed ID: 36934020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-Chain Fatty Acid-Producing Gut Microbiota Is Decreased in Parkinson's Disease but Not in Rapid-Eye-Movement Sleep Behavior Disorder.
    Nishiwaki H; Hamaguchi T; Ito M; Ishida T; Maeda T; Kashihara K; Tsuboi Y; Ueyama J; Shimamura T; Mori H; Kurokawa K; Katsuno M; Hirayama M; Ohno K
    mSystems; 2020 Dec; 5(6):. PubMed ID: 33293403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain-gut-microbiota axis in Parkinson's disease.
    Mulak A; Bonaz B
    World J Gastroenterol; 2015 Oct; 21(37):10609-20. PubMed ID: 26457021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The gut microbiome and cognition in Parkinson's disease: a systematic review.
    Grant H; Anderton R; Gasson N; Lawrence BJ
    Nutr Neurosci; 2023 Oct; 26(10):932-941. PubMed ID: 35965446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential roles of gut microbiota and microbial metabolites in Parkinson's disease.
    Zheng SY; Li HX; Xu RC; Miao WT; Dai MY; Ding ST; Liu HD
    Ageing Res Rev; 2021 Aug; 69():101347. PubMed ID: 33905953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymannuronic acid prevents dopaminergic neuronal loss via brain-gut-microbiota axis in Parkinson's disease model.
    Dong XL; Wang X; Liu F; Liu X; Du ZR; Li RW; Xue CH; Wong KH; Wong WT; Zhao Q; Tang QJ
    Int J Biol Macromol; 2020 Dec; 164():994-1005. PubMed ID: 32710966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway.
    Sun MF; Zhu YL; Zhou ZL; Jia XB; Xu YD; Yang Q; Cui C; Shen YQ
    Brain Behav Immun; 2018 May; 70():48-60. PubMed ID: 29471030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in Gastrointestinal Microbiome Composition in PD: A Pivotal Role of Covariates.
    Cosma-Grigorov A; Meixner H; Mrochen A; Wirtz S; Winkler J; Marxreiter F
    Front Neurol; 2020; 11():1041. PubMed ID: 33071933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.